Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Title Grant Type Focus Area Country Application Due Date Rheumatology Education Healthcare DisparitiesRelease Date:Education Inflammation & Immunology USA Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic BladderRelease Date:Education Internal Medicine Japan Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia TreatmentsRelease Date:Education Rare Disease Japan Equity in Access to Cancer Cachexia Clinical TrialsRelease Date:Quality Improvement Internal Medicine All Infectious Disease FellowshipRelease Date:Fellowship Hospital India Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)Release Date:Fellowship Inflammation & Immunology All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Mayo ClinicReview Process: Expert Review PanelQuality Improvement Rare Disease All 2022 Growth Hormone ResearchRelease Date:Research Rare Disease All Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science ResearchRelease Date:Research Vaccines USA New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel DiseasesRelease Date:Quality Improvement Inflammation & Immunology Canada Improving the Care of Patients with Disorders of Impaired GrowthQuality Improvement Rare Disease All